BioCardia Analyst Price Targets - Benzinga

BioCardia Inc

BCDANASDAQ

Trade with Public

Trade with Public

$1.06

N/A

Ult. Agg.: Oct 9, 11:45 AM

$1.10

0.043.77%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Rapporto azionario

BioCardia Analyst Price Targets - Benzinga

BioCardia Analyst Price Targets

Wall Street analyst price targets and consensus rating for BioCardia (BCDA).

Price Target Range — 7 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$25Upside to Avg. PT+2258.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 24, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Jun 9, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Sep 22, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Dec 18, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Nov 14, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Oct 28, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Aug 21, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Aug 16, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4→$25
Jul 26, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
May 29, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Nov 14, 2023	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Oct 11, 2023	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk